Fig. 4From: Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE studyCumulative incidence of primary non-response and secondary loss of response to anti-TNF therapy in patients with IBD in China. IBD inflammatory bowel disease, TNF tumor necrosis factorBack to article page